Anebulo Pharmaceuticals, Inc.
ANEB • NASDAQ
Anebulo Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard Anthony Cunningham, with a market cap of $33.5M.
CEORichard Anthony Cunningham
Market Cap$33.5M
Biotechnology
Healthcare
Employees2.0
Websiteanebulo.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Anebulo Pharmaceuticals, Inc.
Date
Friday, February 20, 2026 (in 1 week)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.13
Earnings History
Past 12 earnings reports for Anebulo Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q1 2026 | -$0.05Est: -$0.12 | +58.3% | - | — |  10-Q |
| Sep 29, 2025 | Q4 2025 | -$0.05Est: -$0.05 | 0.0% | - | — | 10-K |
| May 13, 2025 | Q3 2025 | -$0.04Est: -$0.05 | +20.0% | - | — | 10-Q |
| Feb 14, 2025 | Q2 2025 | -$0.09Est: -$0.08 | -12.5% | - | — | 10-Q |
| Nov 13, 2024 | Q1 2025 | -$0.08 | — | - | — | 10-Q |
| Sep 25, 2024 | Q4 2024 | -$0.05 | — | - | — | 10-K |
| May 15, 2024 | Q3 2024 | -$0.06Est: -$0.12 | +50.0% | - | — | 10-Q |
| Feb 13, 2024 | Q2 2024 | -$0.11Est: -$0.10 | -10.0% | -Est: - | — | 10-Q |
| Nov 14, 2023 | Q1 2024 | -$0.10Est: -$0.12 | +16.7% | - | — | — |
| Sep 20, 2023 | Q4 2023 | -$0.10Est: -$0.12 | +16.7% | - | — | 10-K |
| May 11, 2023 | Q3 2023 | -$0.11Est: -$0.16 | +31.3% | - | — | 10-Q |
| Feb 10, 2023 | Q2 2023 | -$0.15Est: -$0.11 | -36.4% | - | — | — |